1. Neuronal death in Alzheimer's disease and therapeutic opportunities Author(s): Donev R, Kolev M, Millet B, et al.Source: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE Volume: 13 Issue: 11-12 Pages: 4329-4348 Published: NOV-DEC 2009
2. The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice Author(s): Perucho J, Casarejos MJ, Rubio I, et al. Source: EXPERIMENTAL NEUROLOGY Volume: 221 Issue: 1 Pages: 54-67
3. Lactacystin requires reactive oxygen species and Bax redistribution to induce mitochondria-mediated cell death Author(s): Perez-Alvarez S, Solesio ME, Manzanares J, et al. Source: BRITISH JOURNAL OF PHARMACOLOGY Volume: 158 Issue: 4 Pages: 1121-1130 Published: OCT 2009
4. The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide Author(s): Schubert D, Soucek T, Blouw B Source: EUROPEAN JOURNAL OF NEUROSCIENCE Volume: 29 Issue: 7 Pages: 1323-1334 Published: APR 2009
5. Proteasome inhibitors prevent oxidative stress-induced nerve cell death by a novel mechanism Author(s): Maher P Source: BIOCHEMICAL PHARMACOLOGY Volume: 75 Issue: 10 Pages: 1994-2006 Published: MAY 15 2008
6. Sparvero LJ, Patz S, Brodsky JL, et al. Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast ANALYTICAL BIOCHEMISTRY 370 (2): 162-170 NOV 15 2007
7. Chiba T, Nishimoto I, Aiso S, et al. Neuroprotection against neurodegenerative diseases - Development of a novel hybrid neuroprotective peptide colivelin MOLECULAR NEUROBIOLOGY 35 (1): 55-84 FEB 2007
8. Halliwell B Proteasomal dysfunction: A common feature of neuro degenerative diseases? Implications for the environmental origins of neurodegeneration ANTIOXIDANTS & REDOX SIGNALING 8 (11-12): 2007-2019 NOV-DEC 2006
9. Oh S, Hong HS, Hwang E, et al. Amyloid peptide attenuates the proteasome activity in neuronal cells MECH AGEING DEV 126 (12): 1292-1299 DEC 2005
10. Suh J, Lee YA, Gwag BJ Induction and attenuation of neuronal apoptosis by proteasome inhibitors in murine cortical cell cultures J NEUROCHEM 95 (3): 684-694 NOV 2005
11. Lee EK, Hwang JH, Shin DY, et al. Production of recombinant amyloid-beta peptide 42 as an ubiquitin extension PROTEIN EXPRES PURIF 40 (1): 183-189 MAR 2005
12. Wang YP, Wang ZF, Zhang YC, et al. Effect of amyloid peptides on serum withdrawal-induced cell differentiation and cell viability CELL RES 14 (6): 467-472 DEC 2004
13. Cavallaro S, D'Agata V, Alessi E, et al. Gene expression profiles of apoptotic neurons GENOMICS 84 (3): 485-496 SEP 2004
14. Robinson PA, Ardley HC Ubiquitin-protein ligases - Novel therapeutic targets? CURR PROTEIN PEPT SC 5 (3): 163-176 JUN 2004
15. Uchida K, Kihara N, Hashimoto K, et al. Age-related histological changes in the canine substantia nigra J VET MED SCI 65 (2): 179-185 FEB 2003
16. Forloni G, Terreni L, Bertani I, et al. Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms NEUROBIOL AGING 23 (5): 957-976 SEP-OCT 2002
17. Gracy RW Oxidized proteins & ubiquitin conjugates NEUROBIOL AGING 23 (4): 515-516 JUL-AUG 2002
18. Fernando FS, Conforti L, Tosi S, et al. Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouse GENE 284 (1-2): 23-29 FEB 6 2002
19. Halliwell B Role of free radicals in the neurodegenerative diseases - Therapeutic implications for antioxidant treatment. DRUG AGING 18: (9) 685-716 2001
20. Ding QX, Keller JN Proteasomes and proteasome inhibition in the central nervous system FREE RADICAL BIO MED 31: (5) 574-584 SEP 1 2001
21. Ding, Q., Keller, J. N. (2001). Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J Neurochem 77: 1010-1017
22. Nihashi T, Inao S, Kajita Y, et al.Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion ACTA NEUROCHIR 143: (3) 287-295 2001